Full Text
Shortcutting Drug Development- Economic Benefits Of Using Genome-Wide Association Studies (Gwas) To Reposition Existing Drugs To Other Therapeutic Areas

Abstract

Authors

J.J. Caro B. Richards

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×